Aprin Pharmed




CXCR4 is a type of receptor found in more than 30 types of cancer, including lymphoma, breast, pancreatic, ovarian, and lung cancer (SCLC). Basically, the chemokine receptor CXCR4 is considered a key factor for tumor growth and metastasis. 68Ga-PENTIXAFOR radiopharmaceutical is a new diagnostic radiopharmaceutical that intelligently identifies CXCR4 receptors and in this regard, the positron emission tomography (PET) method is used.

CAS registration number
  • 1341207-62-2
Molecular weight
  • 1221.384 g/mol
molecular formula
  • C60H80N14O14
  • Solid powder
  • Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Therapeutic applications
  • Positron Emission Tomography (PET) imaging or radionuclide therapy